VF
JSPR icon

Virtu Financial’s Jasper Therapeutics JSPR Stock Holding History

Virtu Financial’s Portfolio JSPR Stock Details JSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,410
Closed -$306K – 1599
2024
Q1 		$306K Buy
+10,410
New +$185K 0.02% 610
2023
Q3 		– Sell
-1,094
Closed -$15K – 1594
2023
Q2 		$15K Buy
+1,094
New +$16.3K ﹤0.01% 1307
2023
Q1 		– Sell
-1,449
Closed -$7K – 1794
2022
Q4 		$7K Sell
1,449
-23
-2% -$154 ﹤0.01% 1423
2022
Q3 		$12K Buy
+1,472
New +$26.9K ﹤0.01% 1495
2022
Q1 		– Sell
-2,074
Closed -$163K – 1757
2021
Q4 		$163K Buy
+2,074
New +$194K 0.02% 918

Other funds holding JSPR

VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
QUSVM
Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Virtu Financial's JSPR Position: Q2 2024 in Review

Virtu Financial sold out of Jasper Therapeutics (JSPR) in Q2 2024, closing a stake of 10,410 shares — an estimated $306K sold.

Virtu Financial first reported a position in JSPR in Q4 2021 and held it in 5 quarters. The position peaked at $306K in Q1 2024. 69 funds tracked by Wall St. Rank hold JSPR as of Q2 2024.

  • Virtu Financial reported no remaining Jasper Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Virtu Financial sold 10,410 Jasper Therapeutics shares in Q2 2024, an estimated $306K.
  • Virtu Financial first reported a position in Jasper Therapeutics in Q4 2021 and held it in 5 quarters.
  • Virtu Financial's Jasper Therapeutics position peaked at $306K in Q1 2024.
  • 69 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q2 2024.

Based on Virtu Financial's 13F filing for Q2 2024, filed 9 Aug 2024.